​

Arcadia Biosciences (RKDA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Arcadia Biosciences Revenue Highlights

Latest Revenue (Y)

$5.33M

Latest Revenue (Q)

$1.54M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Arcadia Biosciences Revenue by Period

Arcadia Biosciences Revenue by Year

DateRevenueChange
2023-12-31$5.33M-46.46%
2022-12-31$9.96M46.84%
2021-12-31$6.78M-15.61%
2020-12-31$8.03M587.25%
2019-12-31$1.17M-20.15%
2018-12-31$1.46M-63.64%
2017-12-31$4.03M26.29%
2016-12-31$3.19M-41.12%
2015-12-31$5.41M-22.46%
2014-12-31$6.98M7.78%
2013-12-31$6.48M-7.59%
2012-12-31$7.01M-

Arcadia Biosciences generated $5.33M in revenue during NA 2023, up -46.46% compared to the previous quarter, and up 364.07% compared to the same period a year ago.

Arcadia Biosciences Revenue by Quarter

DateRevenueChange
2024-09-30$1.54M17.69%
2024-06-30$1.31M4.06%
2024-03-31$1.25M7.26%
2023-12-31$1.17M-26.74%
2023-09-30$1.60M14.97%
2023-06-30$1.39M-7.95%
2023-03-31$1.51M50.90%
2022-12-31$1.00M-46.75%
2022-09-30$1.88M-51.32%
2022-06-30$3.86M19.81%
2022-03-31$3.22M48.32%
2021-12-31$2.17M-8.63%
2021-09-30$2.38M69.11%
2021-06-30$1.41M69.69%
2021-03-31$828.00K-88.39%
2020-12-31$7.13M2170.70%
2020-09-30$314.00K11.74%
2020-06-30$281.00K-9.06%
2020-03-31$309.00K-25.72%
2019-12-31$416.00K6.12%
2019-09-30$392.00K93.10%
2019-06-30$203.00K28.48%
2019-03-31$158.00K-64.41%
2018-12-31$444.00K20.00%
2018-09-30$370.00K-15.14%
2018-06-30$436.00K103.74%
2018-03-31$214.00K-85.01%
2017-12-31$1.43M142.44%
2017-09-30$589.00K-40.57%
2017-06-30$991.00K-2.65%
2017-03-31$1.02M88.52%
2016-12-31$540.00K-49.77%
2016-09-30$1.07M49.10%
2016-06-30$721.00K-15.38%
2016-03-31$852.00K-36.70%
2015-12-31$1.35M-26.17%
2015-09-30$1.82M27.48%
2015-06-30$1.43M75.46%
2015-03-31$815.00K-70.87%
2014-12-31$2.80M86.28%
2014-09-30$1.50M15.10%
2014-06-30$1.30M-5.23%
2014-03-31$1.38M-31.22%
2013-12-31$2.00M10.00%
2013-09-30$1.82M-

Arcadia Biosciences generated $1.54M in revenue during Q3 2024, up 17.69% compared to the previous quarter, and up 110.66% compared to the same period a year ago.

Arcadia Biosciences Revenue Breakdown

Arcadia Biosciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20Dec 19Dec 18
Product$8.96M$6.59M$1.04M$814.00K$657.00K
License$879.00K$17.00K$6.80M$67.00K$150.00K
Royalty$117.00K$176.00K$83.00K--
Contract Research And Government Grants--$106.00K$288.00K$657.00K

Arcadia Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 22: Product (90.00%), License (8.83%), and Royalty (1.18%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Product$1.54M$1.31M$1.25M$1.38M$1.51M$993.00K$1.85M$2.95M$3.17M$2.08M$2.32M$1.38M$803.00K$414.00K$245.00K$231.00K$154.00K$329.00K$216.00K$162.00K
License--$10.00K$7.00K$10.00K$862.00K-$17.00K$6.69M$10.00K-$100.00K$50.00K$17.00K------
Royalty------$17.00K$50.00K$50.00K$90.00K$35.00K$26.00K$25.00K$25.00K$16.00K$12.00K$30.00K---
Contract Research And Government Grants--------------$43.00K$38.00K$25.00K$37.00K$159.00K$41.00K

Arcadia Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (100.00%).

Arcadia Biosciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21Dec 20Dec 19Dec 18
INDIA$7.00K$7.00K$100.00K$7.00K$90.00K
ARGENTINA$862.00K$26.00K$6.68M--
CANADA$194.00K$503.00K$354.00K$258.00K$91.00K
GERMANY$57.00K----
UNITED STATES$8.84M$6.00M$761.00K$722.00K$1.17M
SPAIN-$225.00K---
AUSTRIA--$32.00K--
Africa--$106.00K$182.00K$115.00K

Arcadia Biosciences's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (88.75%), ARGENTINA (8.66%), CANADA (1.95%), GERMANY (0.57%), and INDIA (0.07%).

Arcadia Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SENEASeneca Foods$1.46B$304.73M
BRIDBridgford Foods$251.64M$49.26M
FAMIFarmmi$110.36M$49.82M
SNAXStryve Foods$17.71M$5.70B
BTOGBit Origin$6.26M$2.89M
RKDAArcadia Biosciences$5.33M$1.54M

RKDA Revenue FAQ

What is Arcadia Biosciences’s yearly revenue?

Arcadia Biosciences's yearly revenue for 2023 was $5.33M, representing a decrease of -46.46% compared to 2022. The company's yearly revenue for 2022 was $9.96M, representing an increase of 46.84% compared to 2021. RKDA's yearly revenue for 2021 was $6.78M, representing a decrease of -15.61% compared to 2020.

What is Arcadia Biosciences’s quarterly revenue?

Arcadia Biosciences's quarterly revenue for Q3 2024 was $1.54M, a 17.69% increase from the previous quarter (Q2 2024), and a -3.76% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.31M, a 4.06% increase from the previous quarter (Q1 2024), and a -5.98% decrease year-over-year (Q2 2023). RKDA's quarterly revenue for Q1 2024 was $1.26M, a 7.26% increase from the previous quarter (Q4 2023), and a -16.83% decrease year-over-year (Q1 2023).

What is Arcadia Biosciences’s revenue growth rate?

Arcadia Biosciences's revenue growth rate for the last 3 years (2021-2023) was -21.39%, and for the last 5 years (2019-2023) was 355.95%.

What are Arcadia Biosciences’s revenue streams?

Arcadia Biosciences's revenue streams in c 22 are Product, License, and Royalty. Product generated $8.96M in revenue, accounting 90.00% of the company's total revenue, up 36.03% year-over-year. License generated $879K in revenue, accounting 8.83% of the company's total revenue, up 5070.59% year-over-year. Royalty generated $117K in revenue, accounting 1.18% of the company's total revenue, down -33.52% year-over-year.

What is Arcadia Biosciences’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Arcadia Biosciences was Product. This segment made a revenue of $8.96M, representing 90.00% of the company's total revenue.